BioSpace News Archive

Supplemental Biologics License Application (sBLA) Accepted for KEYTRUDA Monotherapy in Patients Whose Tumors Are Tumor Mutational Burden-High (TMB-H) Who Have Progressed Following Prior Treatment

panCELLa is pleased to announce that it will receive advisory services and up to $400,000 from the National Research Council of Canada Industrial Research Assistance Program to help further research and development of its technology platforms for cell therapy.

Magnolia Health, in collaboration with its parent company, Centene Corporation, has recognized Dr. Javel Granados of Desoto Children’s Clinic in Desoto, Mississippi, with a national award for clinical excellence.

Ascentage Pharma announced that it has received approval from the Center for Drug Evaluation of the China National Medical Products Administration for the Phase Ib/II study of APG-2575, the company’s novel Bcl-2‒selective inhibitor, for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

Lodo Therapeutics Corp., a biotechnology company applying its proprietary platform to reinvent natural product drug discovery, announced it has achieved a preclinical milestone in its multi-target strategic collaboration with Genentech, a member of the Roche Group.

Ionis Pharmaceuticals, Inc., the leader in antisense therapeutics, announced that management will present a company overview at the following investor conferences:

Allurion Technologies Announces Submission of US Premarket Approval (PMA) Application for its Flagship Elipse ® Gastric Balloon Submission paves way for the company’s procedureless™ weight loss device to enter the US Company also names Joyce Johnson as Vice President, Regulatory Affairs and Quality Assurance

Veeva to design digital strategies and implementation roadmap to help field teams better connect with HCPs Veeva establishes alliances with Accenture, Deloitte, and other partners to enable industrywide digital transformation initiatives and get customers up and running fast PLEASANTON, Calif.--( BUSINESS WIRE )-- Veeva Systems (NYSE:VEEV) today announced industry alliances to accelerate the industrywide shift toward digital engagement. Toge

During unprecedented times when preserving the health of all Canadians, and in particular seniors and compromised individuals with underlying health conditions is forefront, more and more people have taken on additional caregiving responsibilities for those who are ill with the COVID-19 infection or are self-isolated to prevent the spread.

Hologic, Inc. announced preliminary revenue results for its second fiscal quarter ended March 28, 2020, and withdrew its 2020 financial guidance due to the uncertain economic impact of the COVID-19 pandemic.